Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

High-Risk Veteran Initiative

ClinicalTrials.gov ID: NCT05050643

Public ClinicalTrials.gov record NCT05050643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Aug 1, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Improving Care for Complex, High-Risk Patients in Primary Care (QUE 20-018)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Veterans at high-risk for hospitalization, including those with complex care needs, represent a large population of VHA patients who often do not receive evidence-based primary care practices that would help them avoid the hospital and improve their health. The high-RIsk VETerans (RIVET) Program will implement evidence-based practices that can support VHA Primary Care teams to deliver more comprehensive and patient-centered care, better strategies to manage medications, and avoid unnecessary hospitalizations. The RIVET Program is designed to find the most effective approaches to increasing use of evidence-based practices for high-risk Veterans in primary care, provide rapid data feedback to VHA on high-risk patient care, build capacity for the implementation of evidence-based practices, and train future leaders in high-risk Veteran care.

Study identification

NCT ID
NCT05050643
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Enrollment
17 participants

Conditions and interventions

Conditions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2021
Primary completion
Sep 29, 2025
Completion
Dec 29, 2026
Last update posted
Oct 22, 2025

2021 – 2026

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
VA Greater Los Angeles Healthcare System, Sepulveda, CA Sepulveda California 91343
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Pittsburgh Pennsylvania 15240
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Multimorbidity trials

Other public records listing Multimorbidity. Sorted by last update posted; newest first. Not a recommendation.

All Multimorbidity trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05050643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2025 · Synced Aug 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05050643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →